Department of Surgery, University of Ulsan College of Medicine, Seoul, Korea.
J Korean Med Sci. 2010 Jan;25(1):104-9. doi: 10.3346/jkms.2010.25.1.104. Epub 2009 Dec 26.
Radical nephrectomy with inferior vena cava (IVC) thrombectomy remains the most effective therapeutic option in patients with renal cell carcinoma and IVC tumor thrombus. Cephalic extension of the thrombus is closely related to perioperative morbidity. We purposed to design a safe and successful surgical strategy through a review of our surgical experience and treatment results in 35 patients (male:female=28:7, mean age=56 yr [32-77]) who underwent IVC thrombectomy with radical nephrectomy between January 1997 and December 2006. The limit of tumor extension was level I in 10 patients (28.6%), level II in 17 (48.6%), and level III and IV in 4 patients each (11.4%). Liver mobilization with hepatic vascular exclusion was performed in 12 patients and cardiopulmonary bypass in 7. Thirty-two primary closures, 2 patch closures, and 1 graft interposition were performed. One patient underwent simultaneous pulmonary embolectomy because of an operative pulmonary embolism. There was no operative mortality, and the overall survival at 5-yr was 50.8%. Complete thrombus removal without tumor fragmentation under long venotomy on fully exposed involved IVC is recommended for successful result in a bloodless operative field. The applicability of liver mobilization, hepatic vascular exclusion, and cardiopulmonary bypass, can be determined by the level of thrombus.
根治性肾切除术联合下腔静脉(IVC)血栓切除术仍然是肾细胞癌合并 IVC 肿瘤血栓患者最有效的治疗选择。血栓的头侧延伸与围手术期发病率密切相关。我们旨在通过回顾 1997 年 1 月至 2006 年 12 月期间接受根治性肾切除术和 IVC 血栓切除术的 35 例患者(男/女=28/7,平均年龄 56 岁[32-77])的手术经验和治疗结果,设计一种安全有效的手术策略。10 例患者(28.6%)肿瘤延伸至 I 级,17 例患者(48.6%)至 II 级,4 例患者分别至 III 级和 IV 级(11.4%)。12 例患者行肝游离联合肝血管阻断,7 例行心肺转流。32 例行原发性静脉切开术,2 例行静脉补片修补术,1 例行移植物间置术。1 例患者因术中发生肺动脉栓塞而行同期肺动脉血栓切除术。无手术死亡,5 年总生存率为 50.8%。建议在充分暴露受累 IVC 下进行长静脉切开术,以无血手术野成功去除完整的血栓,避免肿瘤碎片脱落。肝游离、肝血管阻断和心肺转流的适用性可根据血栓的位置确定。